MARSHALL UNIVERSITY

WVU and Marshall collaborate with GameChanger, prevention leaders, and local coalitions to launch 'One State, One Vision,' a comprehensive Prevention Education Plan aimed at addressing substance use in West Virginia schools and communities, supported by the West Virginia Department of Human Services and state Prevention Partners.

Dr. Donald Robinson, a pioneer in psychopharmacology, and his wife Mary Lou, a community leader, established the Dr. Donald and Mary Lou Robinson Scholarship at Marshall University. Their legacy includes groundbreaking research, community service, and support for future medical students.

AI significantly aids in identifying suitable patients for clinical trials, especially in rare diseases, by leveraging global registries and natural history studies to match patient cohorts with trial criteria, expediting recruitment and optimizing trial outcomes.

A clinical trial at Marshall University and Marshall Health Network evaluates the safety and efficacy of oral lofexidine, a non-opioid medication, for newborns with neonatal opioid withdrawal syndrome (NOWS) due to prenatal opioid exposure. The study, sponsored by USWM, LLC through a grant from NIDA, aims to provide a non-opioid treatment option and is ongoing with enrollment targeted to be completed by the end of 2024.